Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 19.79
+0.41 (2.12%)
Jul 1, 2026, 11:29 AM CST
SHA:600285 Market Cap
SHA:600285 has a market cap or net worth of 10.91 billion as of June 30, 2026. Its market cap has decreased by -21.54% in one year.
Market Cap
10.91B
Enterprise Value
10.03B
Revenue
3.96B
Ranking
n/a
PE Ratio
13.94
Stock Price
19.79
Market Cap Chart
Since January 2, 2001, SHA:600285's market cap has increased from 2.12B to 10.91B, an increase of 415.16%. That is a compound annual growth rate of 6.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 10.91B | -6.42% |
| Dec 31, 2025 | 11.66B | -6.54% |
| Dec 31, 2024 | 12.48B | 29.34% |
| Dec 29, 2023 | 9.65B | 31.14% |
| Dec 30, 2022 | 7.36B | -17.51% |
| Dec 31, 2021 | 8.92B | 85.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Aosaikang Pharmaceutical | 11.60B |
| Shenzhen Hepalink Pharmaceutical Group | 11.52B |
| Zhejiang Hisun Pharmaceutical | 11.50B |
| Guobang Pharma | 11.50B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.33B |
| Zhejiang Jiuzhou Pharmaceutical | 11.32B |
| Nanjing King-Friend Biochemical Pharmaceutical | 11.04B |
| Zhejiang Medicine | 10.70B |